High affinity is insufficient for strong B cell activation by HIV broadly neutralising antibodies.
Saved in:
| Title: | High affinity is insufficient for strong B cell activation by HIV broadly neutralising antibodies. |
|---|---|
| Authors: | Rees-Spear C; Institute for Immunity and Transplantation, UCL, London, UK., Payne O; Institute for Immunity and Transplantation, UCL, London, UK., Touizer E; Institute for Immunity and Transplantation, UCL, London, UK., Kennedy A; Institute for Immunity and Transplantation, UCL, London, UK., Muir L; Institute for Immunity and Transplantation, UCL, London, UK., Thomas P; Institute for Immunity and Transplantation, UCL, London, UK., Thomas DeCruz A; London Centre for Nanotechnology, UCL, London, UK., McKendry RA; London Centre for Nanotechnology, UCL, London, UK., Swadling L; Institute for Immunity and Transplantation, UCL, London, UK., van Gils MJ; UMC, Amsterdam, the Netherlands., Voss JE; The Scripps Research Institute, La Jolla, CA, USA., McCoy LE; Institute for Immunity and Transplantation, UCL, London, UK. l.mccoy@ucl.ac.uk. |
| Source: | NPJ vaccines [NPJ Vaccines] 2026 May 02; Vol. 11 (1). Date of Electronic Publication: 2026 May 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
